Risk factor
Low price volatility
Profitability factor
Strong growth
About
Medacta Group S.A. is a worldwide enterprise specializing in the design, production, and distribution of medical devices for both orthopedic and neurosurgical applications. Operating across Europe, North America, the Asia-Pacific region, and numerous other international markets, the company delivers specialized solutions. These include custom kinematic models and three-dimensional planning software, which are employed in various surgical procedures such as those for the hip, knee, and shoulder, as well as in sports medicine and spinal treatments. The firm, established in 1958, maintains its primary corporate office in Castel San Pietro, Switzerland.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, overpriced
Target Price
The average target price of MOVE.SW is 170 and suggests 21.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in